At acadia, our mission is to turn scientific promise into meaningful innovation that makes the difference for underserved neurological disorders and rare disease communities around the world Read more on acad stock here. Is a biopharmaceutical company headquartered in del mar, san diego, california
About acadia pharmaceuticals (get free report) acadia pharmaceuticals inc, a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (cns) disorders and rare diseases in the united states. From developing the first and only treatment for hallucinations and delusions in parkinson’s disease psychosis to commercializing the first therapy for rett syndrome, acadia has consistently advanced care where it is most needed. A biotech story with legs acadia pharmaceuticals is no longer a speculative bet
